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Abstract
Background: TB and HIV co-epidemic is a major public health problem in many parts of the world, particularly in developing
counties. We aimed to summarize the prevalence of TB and HIV co-infection in mainland China, using meta-analysis based
on systematic review of published articles.
Methods: We systematically reviewed published studies, from the MEDLINE and Chinese BioMedical Literature Databases,
on the prevalence of HIV infection among TB patients and on the prevalence of TB among HIV/AIDS population until 15
April 2010, and quantitatively summarized the estimates using meta-analysis.
Results: In total, 29 studies were included in this review, with consistently homogeneous results. TB patients, for whom the
summary prevalence of HIV infection was 0.9% (0.6%–1.4%) in mainland China, were found to be a potential target
population for HIV screening. The prevalence of TB among HIV/AIDS population was 7.2% (4.2%–12.3%), but this was much
higher when the analyses were restricted to AIDS patients (22.8%). Significantly higher prevalence was observed for males
and hospital-based studies.
Conclusions: Our analyses indicated that the prevalence of HIV/TB co-infection in China deserves special attention,
screening of TB among HIV/AIDS populations should be attached more importance, which would be much more helpful for
treatment of both diseases.
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Introduction
Mycobecterium tuberculosis (TB) and human immune defi-
ciency virus (HIV) infections are two major public health problems
in many parts of the world, particularly in many developing
counties [1,2]. TB is the most common opportunistic disease and
cause of the death for those infected with HIV [3]. Similarly, HIV
infection is one of the most important risk factors associated with
an increased risk of latent TB infection progressing to active TB
disease [4,5]. An estimated 1.37 million HIV positive TB patients
were diagnosed globally in 2007, and around 80% of them live in
sub-Saharan Africa [6]. At least one-third of the 33.2 million
people living with HIV worldwide are infected with TB and they
are 20–30 times more likely to develop TB than those without
HIV [6,7]. The challenge of the TB and HIV co-epidemic has
been recognized by World Health Organization, and collaborative
TB/HIV activities were launched in 2004 to manage the TB and
HIV co-infection [8].
The prevalence of HIV and TB within mainland China is high
and the convergence of these two infectious diseases is increasingly
and significantly endangering human health [9,10]. By 1998, HIV
had reached all 31 provinces and was in a phase of exponential
growth. According to the estimates by the Ministry of Health and
the Joint United Nations Programme on HIV/AIDS (UNAIDS),
China has 560,000 to 920,000 people infected by HIV virus by
2009 (http://english.peopledaily.com.cn/90001/90782/90880/
6822651.html). The 4th National Tuberculosis Epidemiological
Sampling Survey, performed in 2000, indicated that the
prevalence of TB infection was 44.5% and the prevalence of
pulmonary TB was 367/10,000 in mainland China [11]. Multiple
epidemiological studies have addressed TB and HIV co-infection
in recent years [12]. However, to our knowledge, the data have
not been systematically evaluated and reported in English. The
objective of this study was to summarize the prevalence of TB and
HIV co-infection in mainland China using a meta-analysis of
published articles.
Materials and Methods
Literature search
Studies addressing the TB and HIV co-infection were identified
by searching for articles in the MEDLINE database and Chinese
BioMedical Literature Database until 15 April 2010 [13]. Various
combinations of the terms ‘‘tuberculosis’’, ‘‘HIV’’, ‘‘AIDS’’, ‘‘co-
infection’’ and ‘‘China’’ were used to screen for potentially
relevant studies. Additional studies were also identified using cross-
referencing.
Inclusion and exclusion criteria
Cross-sectional or cohort studies addressing the prevalence of
HIV infection among TB patients or the prevalence of TB among
HIV/AIDS population were included. If the study was reported in
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included studies, screening of HIV infection was performed by the
routine ELISA test and all ELISA positives were confirmed by
Western Blot. A diagnosis of TB was made based on the combined
evaluation of clinical, radiological, histopathological and labora-
tory features of the patients in accordance with the protocol
established by the National Tuberculosis Prevention and Control
Program (2008): sample smears/cultures positive, or sample
smears/cultures negative but meet all three of the following
clinical criteria (1. symptoms consistent with TB; 2. chest X-ray
suggestive of TB; 3. a positive anti-TB Rx response). Review
articles, and studies in languages other than English or Chinese,
with ,50 participants, from the regions of China other than
mainland (i.e. TaiWan, HongKong and Macao), where the
diagnosis of TB was based on serology methods only, focusing
on incidence rates, and addressing specific high risk populations
(e.g. studies assessing HIV prevalence among TB patients who
were injecting drug users), were excluded.
Data extraction and Statistical analysis
For all included studies, we extracted the following data from
original publications: first author and year of publication; study
site, study base (population-based or hospital-based) and subject
enrollment time; sample size and age of the participants;
prevalence of HIV infection and potential route of infection;
diagnosis criteria of TB and methods of differential identification
of Mycobacteria in clinical samples. In population-based studies,
studied cases were collected from a target population (e.g. from
communities or regional hospitals); in hospital-based studies, cases
were enrolled from specific hospitals and could not cover any
target population. In this review, events of HIV infection and TB
were extracted from the studies, if available, and included in
tabular presentation. For some studies, events had to be calculated
from the reported data.
Meta-analyses on the prevalence of HIV infection among TB
patients and the prevalence of TB among HIV/AIDS population
were carried out using the Comprehensive Meta-Analysis program
(V2.0, Biostat, Englewood, NJ, USA) [14]. Stratified analyses were
performed according to study base (population based or hospital
based), gender of participants (male or female) and studied target
population (i.e. AIDS or HIV/AIDS). Chi square test was used to
assess the differences between the subgroups. Random effects
models were used, taking into account the possibility of
heterogeneity between studies, which was tested with the Q test
(P,0.10 was considered indicative of statistically significant
heterogeneity) and the I
2 statistic (values of 25%, 50% and 75%
are considered to represent low, medium and high heterogeneity
respectively). Begg rank correlation and Egger weighted regression
methods were used to statistically assess publication bias (p,0.05
was considered indicative of statistically significant publication
bias).
Results
As shown in Figure 1, a total of 476 articles published in
Chinese or English were identified. After excluding 46 review
papers and 378 original articles without prevalence data based on
abstract evaluation, 52 studies addressing TB and HIV co-
infection were selected, and the full-text versions were retrieved.
Of these, 23 were excluded based on the exclusion criteria (see List
S1). Finally, 29 studies were included in this review [15–43].
Nineteen studies, from 8 different regions or provinces,
addressing HIV prevalence among TB patients are presented in
Table S1 and Table S2 [16–34]. Fourteen of them were hospital-
based and 5 were population based. Only 8 studies provided
potential route of HIV infection for the studied subjects. Sample
size of the studies ranged from 200 to 9887. A total of 38,101
subjects were included in the meta-analyses. Figure 2 shows the
summarized estimate of HIV prevalence among TB patients in
mainland China (0.9%; 95% confident interval (CI): 0.6%–1.4%;
range 0.1%–4.5%). No evident publication bias was observed
(p=0.57 for Begg rank correlation analysis; p=0.04 for Egger
weighted regression analysis). The studies showed good homoge-
Figure 1. Flow diagram of study identification.
doi:10.1371/journal.pone.0010736.g001
HIV/TB Co-Infection in China
PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10736neity (Q test p,0.01; I
2=92.21). Stratified analyses showed lower
overall prevalence estimates from population-based studies and for
females (p,0.01).
As shown in Table S3 and Table S4, 15 studies on the
prevalence of TB among HIV/AIDS population were included
and 8 of them were population-based [15,18,22–24,35–43].
There are only 3 studies addressing AIDS patients and all the
others addressing both HIV infections and AIDS patients. A
total of 12,127 subjects were included in the meta-analyses.
Figure 3 shows the summarized estimate (7.2%; 95% CI: 4.2%–
12.3%; range 0.5%–35.0%). No evident publication bias was
observed (p=0.17 for Begg rank correlation analysis; p=0.16
for Egger weighted regression analysis). No heterogeneity was
found between studies (Q test p,0.01; I
2=97.92). A much
higher summarized prevalence was observed for studies address-
ing AIDS as compared to those addressing both HIV infections
and AIDS patients (22.8% vs 5.2%, p,0.01). Lower prevalence
was found from population-based studies and for females
(p,0.01).
Discussion
This review addressed the status of TB and HIV co-infection in
mainland China. Twenty four studies were identified and
summarized by meta-analysis. Our results suggest a high
prevalence of TB among HIV/AIDS cases, especially among
Figure 2. Meta-analysis of HIV infection among TB patients.
doi:10.1371/journal.pone.0010736.g002
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should be attached more importance in China which would be
much helpful for treatment of both diseases.
To our knowledge, this is the first study to systematically
review the status of TB and HIV co-infection in mainland
China. TB and HIV co-infection is well recognized as a major
public health problem in woldwide and many investigations
have been performed and published from western countries
[44–46]. The United Nations Joint Programme on HIV/AIDS
(UNAIDS) 2009 report estimated that 33.4 million people are
living with HIV in worldwide, and one third of them are co-
infected with TB [47]. HIV infection increases susceptibility to
TB and is the most potent factor in transferring latent or
recently acquired TB infection to active clinical diseases
[4,5,48]. In addition, TB in high HIV prevalence populations
is a leading cause of morbidity and mortality. TB patients have
been suggested to be an important population for finding of
HIV infections [3,48]. Therefore, prevention and control of co-
infection is vital to reduce the epidemic of both TB and HIV/
AIDS.
HIV infection has a long latent period before progression to
AIDS, which makes the diagnosis, control and treatment more
difficult [49]. When HIV is diagnosed early, appropriately
t i m e di n t e r v e n t i o n sc a nl e a dt oi m p r o v e dh e a l t ho u t c o m e s ,
including slower progression and reduced mortality. Screening
HIV positive patients among the high risk population has been
Figure 3. Meta-analysis of TB prevalence among HIV/AIDS population.
doi:10.1371/journal.pone.0010736.g003
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later in implementing interventions [50–53]. As TB is one of the
most common HIV-related opportunistic infections, and HIV
infected persons are more susceptible to TB, several countries
have recommended HIV screening for TB patients. However,
targeted HIV testing, which is based on provider assessment of
patient risk behaviors, fails to identify a substantial number of
p e r s o n sw h oa r eH I Vi n f e c t e d .T h i si sb e c a u s em a n yi n d i v i d u a l s
may not perceive themselves to be at risk for HIV or do not
disclose their risks. Therefore, routine HIV testing has been
s u g g e s t e dt ob em o r er e a s o n a b l e which also reduces the stigma
associated with testing [54,55]. Up to now, there is no policy or
program implementing routine HIV testing among TB patients
in mainland China. Our analyses showed that there are about
0.9% TB patients were infected with HIV, which suggested a
feasibility of using routine HIV testing among TB patients to
find new infections. However, the low prevalence also raises a
consideration on the problem of cost-effectiveness which is an
important issue should be addressed in the future studies. In
addition, we observed lower summarized prevalence of HIV for
population-based studies as compared to hospital-based studies.
An explanation could be that TB patients who are HIV infected
might be more likely to stay in the hospital because of their
immune deficiency and more complicated clinical manifesta-
tion. The different prevalence of HIV between genders might be
related to the potential differences of high-risk behaviors for
HIV infection. However, more systematically designed studies
are needed to address the factors associated with HIV infection
among TB patients.
Due to the different inclusion criteria, we observed very
different TB prevalence among HIV/AIDS population. For the
studies performed among only AIDS patients, it was as high as
22.8%. For the studies performed among ‘‘HIV infections or
AIDS patients’’, however, it was only 5.2%. This is consistent
with the finding that higher prevalence was observed among
hospital-based studies. People with more advanced stages of
AIDS are easily infected by TB or have poor capability to
control disease development from latent TB infection [3,5,48].
We also observed significant difference between genders.
However, we cannot completely exclude that such difference
is attributed to potential gender-related factors, which may
influence host susceptibilityt ot h ed e v e l o p m e n to fT Ba m o n g
AIDS patients. This finding might be explained by the
demographic factors of the study population, such as the gender
and age distribution of subjects according to disease severity, but
would need verification in future studies [45]. Overall, 7.2%
prevalence of TB among HIV/AIDS subjects suggests it is
necessary to screen or monitor TB for this target population. In
addition, the timing of Highly Active Anti-Retroviral Therapy
(HAART) initiation after starting anti-TB therapy has been
controversial, and optimal treatment regimens for HIV/TB co-
infection are not yet clearly defined [56]. Therefore, early
diagnosis of TB among HIV/AIDS cases will not only promise
an earlier treatment and then better prognosis, but also provide
more opportunities for deciding proper timing of HAART
initiation [57].
The limitations of this study should be kept in mind. First, as
positive results are more likely to be published, publication bias
cannot be excluded completely, although no major publication
bias was observed in the meta-analyses. Second, due to the
specific high-risk behaviors for TB and HIV infection, the
selection of subjects might make results prone to potential
selection bias even as we have excluded two studies performed
among prisoners and injecting drug users. Third, most of the
included studies (27/29) were published in Chinese, quality of
the reports could not be expected as well as the articles from
English Journals. For example, not all necessary information,
even age and gender of the study population, could be
obtained from all included studies. Therefore, relevant
stratified analyses (e.g. with respect to the regions or HIV
infection routes) could not be performed to disclose more
detailed characteristics of the co-infection and its related risk
factors [45]. In addition, as prevalence of TB is very dependent
on the disease stage or immune level of HIV/AIDS patients,
timing of the cross-sectional survey is very important and
should be considered when interpret the results. Unfortunate-
ly, very few included studies provided relevant detailed
information. Finally, due to the limited number of relevant
studies, incidence rate of TB and HIV co-infection was not
addressed in this study.
In conclusion, our analyses suggest that it is necessary to
attach importance to HIV/TB co-infection in mainland
China, especially screening of TB among HIV/AIDS popula-
tions should be attached more importance which would be
much helpful for treatment of both diseases. To ensure a
precise estimate of the epidemic status of co-infection, further
large scale or even countrywide studies are needed. Such
studies will not only provide more tangible proof in promoting
the development of effective strategy for diagnosis and
surveillance but are also vital in reducing the prevalence
of and in improving the prognosis from both TB and HIV/
AIDS.
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